Literature DB >> 23665817

Patient attitudes toward transaxillary robot-assisted thyroidectomy.

Dimitrios Linos1, Andreas Kiriakopoulos, Athanassios Petralias.   

Abstract

BACKGROUND: The transaxillary robot-assisted technique constitutes an acceptable treatment option for patients requiring thyroidectomy. However, patients' attitudes toward this new technique have not yet been analyzed.
METHODS: A sample of 596 randomly selected patients who underwent thyroidectomy between January 2000 and March 2010 was assessed. We evaluated patients' attitudes toward transaxillary robot-assisted thyroidectomy, taking into account the validated Patient Scar Assessment Questionnaire, the SF-36 Health Survey Questionnaire, and 11 sociodemographic and surgical patient characteristics.
RESULTS: Only 11.6 % of the patients would prefer to have been treated with the transaxillary method. Most patients had concerns that it would be a more painful procedure (39.2 %), and they expressed satisfaction with the existing esthetic outcome (29.1 %); other concerns were that the robotic approach would be of longer duration (25.4 %) and at higher cost (15.5 %). Nevertheless, the worse the appearance of the neck scar the more preferable is the new method (p = 0.025), a result that holds true irrespective of patients' physical health, the invasive procedure attained (conventional or minimal), and the presence of postoperative complications, among other characteristics. Patients diagnosed with a benign or uncertain neoplasm (p = 0.022) and younger patients (p = 0.003) held a more positive view of the new method.
CONCLUSIONS: Patients who have undergone conventional thyroidectomy via the usual neck incision do not express a preference for the transaxillary method. The reasons given include various perceived disadvantages of the robotic procedure (increased pain, longer operative times, and higher cost). Younger patients, patients with poor appearance of their neck scar, and patients with benign thyroid pathology seem to hold a more positive attitude toward the robotic approach.

Entities:  

Mesh:

Year:  2013        PMID: 23665817     DOI: 10.1007/s00268-013-2090-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  28 in total

1.  Robot-assisted endoscopic surgery for thyroid cancer: experience with the first 100 patients.

Authors:  Sang-Wook Kang; Jong Ju Jeong; Ji-Sup Yun; Tae Yon Sung; Seung Chul Lee; Yong Sang Lee; Kee-Hyun Nam; Hang Seok Chang; Woong Youn Chung; Cheong Soo Park
Journal:  Surg Endosc       Date:  2009-03-05       Impact factor: 4.584

2.  Robot-assisted endoscopic thyroidectomy for thyroid malignancies using a gasless transaxillary approach.

Authors:  Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Hang Seok Chang; Woong Youn Chung; Cheong Soo Park
Journal:  J Am Coll Surg       Date:  2009-06-12       Impact factor: 6.113

3.  Robotic thyroid surgery using a gasless, transaxillary approach and the da Vinci S system: the operative outcomes of 338 consecutive patients.

Authors:  Sang-Wook Kang; Seung Chul Lee; So Hee Lee; Kang Young Lee; Jong Ju Jeong; Yong Sang Lee; Kee-Hyun Nam; Hang Seok Chang; Woong Youn Chung; Cheong Soo Park
Journal:  Surgery       Date:  2009-10-30       Impact factor: 3.982

4.  The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  J E Ware; M Kosinski; B Gandek; N K Aaronson; G Apolone; P Bech; J Brazier; M Bullinger; S Kaasa; A Leplège; L Prieto; M Sullivan
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

5.  Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

Authors:  J E Ware; B Gandek
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

6.  Prospects of robotic thyroidectomy using a gasless, transaxillary approach for the management of thyroid carcinoma.

Authors:  Sang-Wook Kang; Jae Hyun Park; Jun Soo Jeong; Cho Rok Lee; Seulkee Park; So Hee Lee; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2011-08       Impact factor: 1.719

7.  Psychometric evaluation of Patient Scar Assessment Questionnaire following thyroid and parathyroid surgery.

Authors:  Konstantinos P Economopoulos; Athanasios Petralias; Eleni Linos; Dimitrios Linos
Journal:  Thyroid       Date:  2012-01-06       Impact factor: 6.568

8.  Robot assisted transaxillary surgery (RATS) for the removal of thyroid and parathyroid glands.

Authors:  Christine S Landry; Elizabeth G Grubbs; G Stephen Morris; Nadine S Turner; F Christopher Holsinger; Jeffrey E Lee; Nancy D Perrier
Journal:  Surgery       Date:  2010-10-14       Impact factor: 3.982

Review 9.  Minimally invasive thyroid and parathyroid surgery is not a question of length of the incision.

Authors:  Jean-François Henry
Journal:  Langenbecks Arch Surg       Date:  2008-08-21       Impact factor: 3.445

10.  A comparison of surgical outcomes between endoscopic and robotically assisted thyroidectomy: the authors' initial experience.

Authors:  Brian Hung-Hin Lang; Man-Po Chow
Journal:  Surg Endosc       Date:  2010-11-19       Impact factor: 4.584

View more
  3 in total

1.  Cross-cultural adaptation and psychometric validation of the Patient Scar Assessment Questionnaire to the Spanish language in head and neck surgery.

Authors:  Santiago Restrepo; Santiago Rojas; Alvaro Sanabria
Journal:  Int Wound J       Date:  2019-11-03       Impact factor: 3.315

2.  A survey of preferences regarding surgical approach to thyroid surgery.

Authors:  Nicholas E Coorough; David F Schneider; Monica Woll Rosen; Rebecca S Sippel; Herbert Chen; Margaret L Schwarze; Haggi Mazeh
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

3.  Health-Related Quality of Life and Cosmesis After Thyroidectomy: Long-Term Outcomes.

Authors:  Dimitrios Linos; Spyridon Christodoulou; Vassiliki Kitsou; Angeliki Karachaliou; Spyridon Ntelis; Athanassios Petralias
Journal:  World J Surg       Date:  2020-01       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.